AstraZeneca adds to cancer drug portfolio

18-10-2013

AstraZeneca adds to cancer drug portfolio

UK-based pharmaceutical company AstraZeneca announced on October 15 that its biologics R&D subsidiary MedImmune had acquired cancer drug maker Spirogen.


AstraZeneca, oncology, cancer drug portfolio, MedImmune, Spirogen

LSIPR